This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tetra Tech (TTEK) Q2 Earnings Top Estimates, Revenues Up
by Zacks Equity Research
Tetra Tech's (TTEK) second-quarter fiscal 2021 net revenues increase 2.5%, driven by strong performance of its Government Services Group segment.
Sharps Compliance (SMED) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of 150.00% and 22.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Sharps Compliance (SMED): Can Its 13.5% Jump Turn into More Strength?
by Zacks Equity Research
Sharps Compliance (SMED) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Tetra Tech (TTEK) Secures $36M Contract From Federal Client
by Zacks Equity Research
Tetra Tech's (TTEK) contracts won from USACE will likely help strengthen business from federal clients.
Tetra Tech (TTEK) Acquires IBRA-RMAC, Enhances Offerings
by Zacks Equity Research
Tetra Tech's (TTEK) buyout of IBRA-RMAC will enable it to enhance its capabilities in digital water consulting services.
Tetra Tech (TTEK) Secures Multiple-Award Contract From USACE
by Zacks Equity Research
Tetra Tech's (TTEK) contract with USACE will help the latter in restoring and conserving the natural environment.
Zacks Industry Outlook Highlights: Tetra Tech, Energy Recovery, Heritage-Crystal Clean and Sharps Compliance
by Zacks Equity Research
Zacks Industry Outlook Highlights: Tetra Tech, Energy Recovery, Heritage-Crystal Clean and Sharps Compliance
4 Stocks to Outshine in the Thriving Pollution Control Industry
by Avisekh Bhattacharjee
Rise in adoption of air pollution control equipment, health concerns and addition of oil rigs are driving the pollution control industry. Product upgrade costs continue to be high.
HCCI vs. SMED: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HCCI vs. SMED: Which Stock Is the Better Value Option?
Donaldson (DCI) Exhibits Bright Prospects, Headwinds Remain
by Zacks Equity Research
Donaldson (DCI) is likely to benefit from its strong portfolio of products, focus on innovation and growth investments. However, softness across its end markets poses a concern.
Is Sharps Compliance (SMED) a Great Growth Stock?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Sharps Compliance (SMED).
Here's Why it is Worth Investing in Tetra Tech (TTEK) Now
by Zacks Equity Research
Tetra Tech (TTEK) is poised to benefit from diversified business structure, acquired assets and shareholder-friendly policies.
Donaldson (DCI) Tops on Q2 Earnings, Gives Impressive View
by Zacks Equity Research
Donaldson's (DCI) Q2 earnings surpass estimates and increase y/y on sales growth and margin improvement. It provides impressive earnings projections for fiscal 2021.
Zacks.com featured highlights include: Atlantic Capital Bancshares, ICICI Bank, Sharps Compliance and Northern Technologies International
by Zacks Equity Research
Zacks.com featured highlights include: Atlantic Capital Bancshares, ICICI Bank, Sharps Compliance and Northern Technologies International
Sharps Compliance's (SMED) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Sharps Compliance (SMED).
Sharps Compliance (SMED) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of 16.67% and 6.07%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
HCCI or SMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HCCI vs. SMED: Which Stock Is the Better Value Option?
HCCI or SMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HCCI vs. SMED: Which Stock Is the Better Value Option?
Sharps Compliance (SMED) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sharps Compliance (SMED) delivered earnings and revenue surprises of -140.00% and -12.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Sharps Compliance (SMED) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Sharps Compliance (SMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CECE vs. SMED: Which Stock Is the Better Value Option?
by Zacks Equity Research
CECE vs. SMED: Which Stock Is the Better Value Option?
CECE vs. SMED: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CECE vs. SMED: Which Stock Is the Better Value Option?
CECE vs. SMED: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CECE vs. SMED: Which Stock Is the Better Value Option?
CECE or SMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CECE vs. SMED: Which Stock Is the Better Value Option?
CECE vs. SMED: Which Stock Is the Better Value Option?
by Zacks Equity Research
CECE vs. SMED: Which Stock Is the Better Value Option?